NCT04190329

Brief Summary

The aim of the prospective study is to assess the feasibility of a screening and baseline measurement protocol that is planned for a main study (PRÄP-GO) in a collective of 30 patients ageing 70+ scheduled for elective surgery. Comprehensive geriatric assessment scores and modified Fried frailty phenotype component evaluation are performed in all patients at baseline before elective surgery. The assessment of cognitive tests is conducted with a battery of neuropsychological tests, computer-based tests from the Cambridge Neuropsychological Test Automated Battery \[CANTAB®\] and non-computer based tests. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) represent robust (0), pre-frail (1-2), and frail (3-5) health status. 10 patients without Frailty, 10 patients with Pre-Frailty and 10 patients with Frailty should be analyzed in this study and receive further comprehensive geriatric assessment testing up to seven days after surgery/discharge (before 7 postoperative days).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 9, 2019

Completed
9 days until next milestone

Study Start

First participant enrolled

December 18, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2020

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2020

Completed
Last Updated

October 8, 2020

Status Verified

October 1, 2020

Enrollment Period

7 months

First QC Date

November 28, 2019

Last Update Submit

October 7, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Duration to run the test battery

    The duration of the screening test battery is measured with a stopwatch.

    1 day (Once only at screening)

Secondary Outcomes (16)

  • Acceptance of test battery

    1 day (Once only at screening)

  • Problems to conduct the test battery

    1 day (Once only at screening)

  • Change in pain

    Baseline, day 3 after surgery and discharge or day 7 after surgery

  • Intelligibility of the patient Diary 1

    Up to day 7 after surgery

  • Intelligibility of the patient Diary 2

    Up to day 7 after surgery

  • +11 more secondary outcomes

Other Outcomes (3)

  • Cognitive Status

    1 day (Once only at screening)

  • Depression

    1 day (Once only at screening)

  • Frailty

    1 day (Once only at screening)

Study Arms (3)

10 non-frail (robust) study patients

Patients fulfill 0 criteria according to modified Fried frailty score.

10 pre-frail study patients

Patients fulfill 1-2 criteria criteria according to modified Fried frailty score.

10 frail study patients

Patients fulfill 3, 4 or 5 criteria according to modified Fried frailty score.

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing elective surgery aged ≥70 years, including 10 patients without Frailty, 10 patients with Pre-Frailty and 10 patients with Frailty.

You may qualify if:

  • Age ≥ 70 years
  • Male and female patients
  • elective surgery
  • Expected anesthesia duration\> 60min

You may not qualify if:

  • Severe cardiological or pulmonary disease (NYHA IV, Gold IV)
  • Intracranial interventions
  • Moribund patients (palliative situation)
  • Not enough language skills
  • Non-consenting patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin

Berlin, 13353, Germany

Location

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Claudia Spies, MD Prof.

    Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité Univerisitätsmedizin Berlin

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin

Study Record Dates

First Submitted

November 28, 2019

First Posted

December 9, 2019

Study Start

December 18, 2019

Primary Completion

July 16, 2020

Study Completion

July 20, 2020

Last Updated

October 8, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations